ImmuPharma PLC (AIM:IMM) says it's in active talks with several global commercial partners following significant scientific breakthroughs in its flagship autoimmune programme, P140. Releasing its full-year results, the company said the findings enabled it to bolster its intellectual property portfolio and make a stronger case for potential commercialisation..
Arecor Therapeutics PLC (AIM:AREC) has teamed up with US-based Skye Bioscience to reformulate an experimental obesity drug using its Arestat tech. The deal gives Arecor a shot at licensing revenues in the red-hot weight-loss market.
Creo Medical Group PLC (AIM:CREO) kicked off 2025 strong, with sales growth driven by new surgical tools and expanded partnerships. It’s targeting up to 60% growth in core tech sales this year.
Anglo Asian Mining PLC (AIM:AAZ, OTC:AGXKF) has started production at its Gilar mine in Azerbaijan, pulling out high-grade copper and gold. It marks a big step in the group’s shift to become a mid-tier copper producer.
Kodal Minerals PLC (AIM:KOD) says reports of blocked lithium exports in Mali are wrong and that permitting talks are progressing well. It’s stockpiled 27,000 tonnes of material and expects shipments to begin soon.
Follow us and subscribe on YouTube, our social channels and on proactiveinvestors.co.uk.
